Gilbert CisnerosSell
AMRX Common Stock · Transaction May 29, 2019 · Filed Jun 18, 2019 · Amount pending receipt enrichment
NASDAQ NMS - GLOBAL MARKET · AMRX
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Amneal Pharmaceuticals Inc
Pharmaceuticals
$18.14
Veridion Score
BETAHIGH CONF · 6/6 factorsFri Aug 7 · last completed session · Pre-market · regular session opens 9:30 ET · AMRX
MethodologyAMRX
Amneal Pharmaceuticals Inc
Fri Aug 7 · last completed session · Pre-market · regular session opens 9:30 ET
BUY BIAS
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
74/ 100
Veridion Score
BUY BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Fri Aug 7 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is AMRX moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Amneal Pharmaceuticals Inc
PHARMACEUTICAL PREPARATIONSListed since
2018
Employees
9K
Country
US
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$18.14
Last session
Day high
$18.14
Last session
Day low
$18.14
Last session
Previous close
$18.14
52W high
$19.10
-5.03% from high
52W low
$8.84
91% of range
Market cap
$5.8B
P/E
40.31×
EPS
$0.4500
Beta
0.11
Shares out
319.3M
Avg volume
2.1M
VWAP
$18.14
Last session
Price history computed in-house
1W
-3.77%
1M
+6.64%
3M
+43.97%
1Y
+112.41%
YTD
+43.97%
SMA 50 $16.65 · above
SMA 200 $13.69 · above
52W position 91%
AMRX overview
Veridion Score
74
6 of 6 factors measured
Congress receipts
2
Gilbert Cisneros · Sale
13F holders
None on file
Related filings and maps
Public disclosures
Congress activity in AMRX
Official filing ↗
Josh GottheimerSell
AMRX Common Stock · Transaction May 24, 2019 · Filed Jun 15, 2019 · Amount pending receipt enrichment
Federal contracts
AMRX contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for AMRX in this window.
Lobbying spend
AMRX lobbying filings, year to date.
Registered lobbying filings matched to Amneal Pharmaceuticals Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for AMRX in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for AMRX.
Options
Sovereign unlock shows live options positioning for AMRX.